Ray Kurzweil - Jul 8, 2022 Form 4/A - Amendment Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role: Director
Signature: /s/ John S. Hess, Jr. under Power of Attorney
Stock symbol: UTHR
Transactions as of: Jul 8, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 7/11/2022, 04:30 PM
Date Of Original Report: Jul 8, 2022
Previous filing: Jul 8, 2022
Next filing: Aug 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UTHR	Common Stock	Options Exercise	$0	+1.08K	+11.71%	$0.00	10.3K	Jul 8, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UTHR	Restricted Stock Unit	Options Exercise	$0	-1.08K	-100%	$0.00^*	0	Jul 8, 2022	Common Stock	1.08K	$0.00	Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment corrects an overstatement of the number of restricted stock units that vested on July 8, 2022, and the number of resulting shares of common stock received by the reporting person. In both cases, the original number reported (3,230 restricted stock units / shares of common stock) has been corrected (1,080 restricted stock units / shares of common stock).
F2	Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock.
F3	Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F4	Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.